Klein, Pavel http://orcid.org/0000-0001-7244-3722
Bourikas, Dimitrios http://orcid.org/0009-0005-4503-0734
Funding for this research was provided by:
UCB Pharma
Article History
Received: 13 March 2024
Accepted: 16 April 2024
First Online: 29 May 2024
Declarations
:
: Pavel Klein has served as a consultant, advisory board member or speaker for Abbott, Angelini, Aquestive, Arvelle Therapeutics, Aucta Pharmaceuticals, Dr. Reddy’s, Eisai, Jazz Pharmaceuticals, Neurelis, Neurona, SK Life Science, Sunovion, UCB Pharma, UNEEG, UniQure; is a member of the Medical Advisory Board of Stratus and of the Scientific Advisory Board of OB Pharma; is the CEO of PrevEp, Inc; and has received research support from CURE/Department of Defense and from the NIH/SBIR. Dimitrios Bourikas is a salaried employee of UCB Pharma and has received UCB Pharma stock from his employment.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.